CACNA1C and schizophrenia: Genetic variation of CACNA1C has been associated with neurodevelopmental delays and disorders including schizophrenia, autism, and bipolar disorder [48–51], and DNAm methylation of CACNA1C has been associated with bipolar disorder [52], suggesting that maternal ACEs may put children at greater risk for these disorders.